Table 6.
The 10 most-enriched KEGG pathways for the target genes of known miRNAs
| Pathway | Target genes with pathway annotation | P-value | Pathway ID |
|---|---|---|---|
| Metabolic pathways | 1321 (12.44 %) | 0.4507364 | ko01100 |
| Pathways in cancer | 373 (3.51 %) | 0.8069502 | ko05200 |
| Biosynthesis of secondary metabolites | 367 (3.46 %) | 0.8097889 | ko01110 |
| Regulation of actin cytoskeleton | 337 (3.17 %) | 0.8241077 | ko04810 |
| MAPK signaling pathway | 322 (3.03 %) | 0.8313458 | ko04010 |
| HTLV-I infection | 297 (2.8 %) | 0.8435271 | ko05166 |
| Endocytosis | 292 (2.75 %) | 0.8459811 | ko04144 |
| Focal adhesion | 285 (2.68 %) | 0.8494267 | ko04510 |
| Tight junction | 266 (2.51 %) | 0.8588381 | ko04530 |
| Tuberculosis | 262 (2.47 %) | 0.8608305 | ko05152 |
| Phagosome | 251 (2.36 %) | 0.8663294 | ko04145 |
| Epstein-Barr virus infection | 244 (2.3 %) | 0.869844 | ko05169 |
| Neuroactive ligand-receptor interaction | 239 (2.25 %) | 0.8723616 | ko04080 |
| Cytokine-cytokine receptor interaction | 237 (2.23 %) | 0.8733703 | ko04060 |
| Influenza A | 236 (2.22 %) | 0.873875 | ko05164 |